Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc.verified

CRXTQ

Price:

$0.0014

Market Cap:

$0

Clarus Therapeutics Holdings, Inc. is a pharmaceutical enterprise dedicated to developing and marketing oral testosterone replacement therapies across the United States. Its primary offering is JATENZO, an oral soft gel formulation of testosterone undecanoate, prescribed for men suffering from hypogonadism. The company has also entered into licensing agreements, including one with HavaH Therapeutics for androgen treatments targeting inflammatory breast disease and specific types of breast cancer. Additionally, Clarus holds an agreement with The Royal Institution for the Advancement of Learning/McGill University to advance and commercialize McGill's exclusive technology, which is designed to ...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2021-02-09

Stock Exchange

OTC

Ticker

CRXTQ

The Enterprise Value as of June 2026 (TTM) for Clarus Therapeutics Holdings, Inc. (CRXTQ) is 15.85M

According to Clarus Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.85M. This represents a change of -63.36% compared to the average of 43.27M of the last 4 quarters.

Clarus Therapeutics Holdings, Inc. (CRXTQ) Historical Enterprise Value (quarterly & annually)

How has CRXTQ Enterprise Value performed in the past?

The mean historical Enterprise Value of Clarus Therapeutics Holdings, Inc. over the last ten years is 122.50M. The current 15.85M Enterprise Value has changed 1.19% with respect to the historical average. Over the past ten years (40 quarters), CRXTQ's Enterprise Value was at its highest in in the June 2021 quarter at 321.37M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

122.50M

Median

122.50M

Minimum

74.24M

Maximum

170.76M

Clarus Therapeutics Holdings, Inc. (CRXTQ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Clarus Therapeutics Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 170.76M

Minimum Annual Increase = -56.53%

Minimum Annual Enterprise Value = 74.24M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202174.24M-56.53%

Clarus Therapeutics Holdings, Inc. (CRXTQ) Average Enterprise Value

How has CRXTQ Enterprise Value performed in the past?

The current Enterprise Value of Clarus Therapeutics Holdings, Inc. (CRXTQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

122.50M

5-year avg

122.50M

10-year avg

122.50M

Clarus Therapeutics Holdings, Inc. (CRXTQ) Enterprise Value vs. Peers

How is CRXTQ’s Enterprise Value compared to its peers?

Clarus Therapeutics Holdings, Inc.’s Enterprise Value is less than Endo International plc (6.57B), greater than Nexeon MedSystems Inc. (3.41M), greater than Health-Chem Corporation (6.55M), less than Invitae Corporation (1.50B), greater than PotNetwork Holdings, Inc. (4.56M), greater than Predictive Technology Group, Inc. (7.51M), greater than Ontrak, Inc. (5.59M), less than Aleafia Health Inc. (53.94M), less than Unrivaled Brands, Inc. (48.42M), greater than Skylight Health Group Inc. (5.34M),

Build a custom stock screener for Clarus Therapeutics Holdings, Inc. (CRXTQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clarus Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clarus Therapeutics Holdings, Inc. (CRXTQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clarus Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Clarus Therapeutics Holdings, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Clarus Therapeutics Holdings, Inc. (CRXTQ)?

What is the 3-year average Enterprise Value for Clarus Therapeutics Holdings, Inc. (CRXTQ)?

What is the 5-year average Enterprise Value for Clarus Therapeutics Holdings, Inc. (CRXTQ)?

How does the current Enterprise Value for Clarus Therapeutics Holdings, Inc. (CRXTQ) compare to its historical average?